UBS Group’s Inception Growth Acquisition Limited Rights IGTAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-99
Closed -$12 10288
2024
Q2
$12 Hold
99
﹤0.01% 9340
2024
Q1
$20 Buy
+99
New +$17 ﹤0.01% 9035
2023
Q4
Sell
-3,310
Closed -$556 10089
2023
Q3
$556 Buy
3,310
+3,295
+21,967% +$534 ﹤0.01% 8408
2023
Q2
$3 Buy
+15
New +$2 ﹤0.01% 8787
2023
Q1
Sell
-1,600
Closed -$144 10643
2022
Q4
$144 Sell
1,600
-2,699
-63% -$228 ﹤0.01% 10357
2022
Q3
$0 Hold
4,299
﹤0.01% 11107
2022
Q2
$0 Buy
4,299
+2,749
+177% +$382 ﹤0.01% 11116
2022
Q1
$0 Buy
+1,550
New +$270 ﹤0.01% 11062

Other funds holding IGTAR

UBS Group's IGTAR Position: Q3 2024 in Review

UBS Group sold out of Inception Growth Acquisition Limited Rights (IGTAR) in Q3 2024, closing a stake of 99 shares — an estimated $12 sold.

UBS Group first reported a position in IGTAR in Q1 2022 and held it in 8 quarters. The position peaked at $556 in Q3 2023. 25 funds tracked by Wall St. Rank hold IGTAR as of Q3 2024.

  • UBS Group reported no remaining Inception Growth Acquisition Limited Rights position as of Q3 2024 after selling out during the quarter.
  • UBS Group sold 99 Inception Growth Acquisition Limited Rights shares in Q3 2024, an estimated $12.
  • UBS Group first reported a position in Inception Growth Acquisition Limited Rights in Q1 2022 and held it in 8 quarters.
  • UBS Group's Inception Growth Acquisition Limited Rights position peaked at $556 in Q3 2023.
  • 25 funds tracked by Wall St. Rank held Inception Growth Acquisition Limited Rights as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.